Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents

Trial Profile

Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Nov 2018

At a glance

  • Drugs Aspirin (Primary) ; Aspirin (Primary) ; Clopidogrel (Primary) ; Everolimus; Paclitaxel; Sirolimus; Zotarolimus
  • Indications Coronary artery disease; Coronary stent thrombosis
  • Focus Therapeutic Use
  • Acronyms ADAPT-DES
  • Most Recent Events

    • 23 Nov 2018 Results evaluating adverse ischemic and bleeding events among patients with and without acute coronary syndromes published in the American Journal of Cardiology
    • 28 Jun 2017 Results (n=8374) of meditation analysis assessing effect of platelet reactivity on risk of thrombotic events published in the American Journal of Cardiology
    • 07 Oct 2016 Results published in the American Journal of Cardiology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top